We are live on ! Find out more
NWBO

Northwest Biotherapeutics
NWBO

Delisted

NWBO was delisted on the 16th of December, 2016.

20 hedge funds and large institutions have $8.95M invested in Northwest Biotherapeutics in 2013 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

7.92% more ownership

Funds ownership: 0% → 7.92% (+7.9%)

Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
–
Reduced
–
Closed
–
Calls
$41K
Puts
–
Net Calls
+$41K
Net Calls Change
+$41K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NWBO Hedge Fund Activity: Q2 2013 in Review

20 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics (NWBO) for Q2 2013, worth a combined $8.95M.

Buyers outnumbered sellers: 20 funds opened new NWBO positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.

  • 20 institutional investors held Northwest Biotherapeutics (NWBO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $8.95M of Northwest Biotherapeutics stock for Q2 2013.
  • 20 funds opened new Northwest Biotherapeutics positions in Q2 2013 and 0 closed out, a net change of +20 holders.

Based on aggregated 13F filings for Q2 2013.